However, plasma LPS and LBP levels were not different between the NAFLD subgroups and did not differ in obese individuals with normal liver histology compared with patients with NASH (Table 1 and Fig 2A and 2B). The gene discussed is LBP; the disease is metabolic dysfunction-associated steatotic liver disease.